Last checked at 20 Dec 2021 07:53
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News3
GSK Share
Chat2
GSK Share
Trades5,646
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,636.00
Bid:
1,638.00
Ask:
1,639.00
Change:
-15.00 (-0.91%)
Spread:
1.00 (0.061%)
Open:
1,656.50
High:
1,661.50
Low:
1,635.50
Prev. Close:
1,651.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.20 Dec 2021 07:40
Glaxo appoints ex-Tesco boss as chair of new consumer healthcare business
(Sharecast News) - GlaxoSmithKline has appointed former Tesco boss Sir Dave Lewis as chairman of its new consumer healthcare business with effect from 1 January 2022.
Read more20 Dec 2021 07:13
Former Tesco boss Lewis to chair GSK health spin-off
LONDON, Dec 20 (Reuters) - GlaxoSmithKline on Monday named former Tesco CEO Dave Lewis as non-executive chair designate of the new Consumer Healthcare company which will result from the proposed demerger from GSK in 2022.It said Lewis' appointment...
Read more19 Dec 2021 20:43
UPDATE 1-GSK picks ex-Tesco chief Lewis to chair consumer healthcare arm -source
(Changes sourcing, background)By Anirudh SaligramaDec 19 (Reuters) - British drugmaker GlaxoSmithKline Plc has picked Dave Lewis, former chief executive of Tesco Plc, to chair its consumer healthcare unit, which is due to be spun off next year, a ...
Read more19 Dec 2021 17:19
GSK picks ex-Tesco chief Lewis to head spun-off consumer healthcare arm - Sky News
Dec 19 (Reuters) - GlaxoSmithKline Plc has picked former Chief Executive Officer of Tesco Plc Dave Lewis to head GSK's consumer healthcare unit, which is being spun off into a standalone business, Sky News reported https://bit.ly/3p8T3zo on Sunda...
Read more17 Dec 2021 14:18
GlaxoSmithKline's Covid treatment Xevudy authorised by EU regulators
GlaxoSmithKline's Covid treatment Xevudy authorised by EU regulators
Read more17 Dec 2021 14:02
GlaxoSmithKline Covid treatment approved for use in EU
(Sharecast News) - GlaxoSmithKline and Vir Biotechnology said on Friday that the European Commission has given marketing authorisation to Xevudy - sotrovimab - for the early treatment of Covid-19.
Read more16 Dec 2021 12:57
UPDATE 2-AstraZeneca therapy works against Omicron; results mixed for Regeneron
* Evusheld retains neutralising activity against Omicron* REGEN-COV showed diminished potency; active against Delta* More data on AstraZeneca's Evusheld expected 'very soon' (Writes through with details on AstraZeneca's drug, background)By Mrinalika...
Read more15 Dec 2021 09:32
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response
Read more15 Dec 2021 07:44
LONDON MARKET PRE-OPEN: UK inflation races; GSK in decent booster data
LONDON MARKET PRE-OPEN: UK inflation races; GSK in decent booster data
Read more15 Dec 2021 07:29
UPDATE 3-Sanofi, GSK delay data on COVID-19 vaccine booster candidate til 2022
(Recasts, adds details, comments)By Benoit Van OverstraetenPARIS, Dec 15 (Reuters) - Sanofi and GlaxoSmithKline said on Wednesday they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first...
Read more15 Dec 2021 07:29
UPDATE 2-Sanofi, GSK say COVID-19 vaccine booster candidate give good immune response
(Adds details throughout)By Benoit Van OverstraetenPARIS, Dec 15 (Reuters) - Sanofi and GlaxoSmithKline said on Wednesday a single booster dose of their COVID-19 vaccine candidate provided strong immune responses, preliminary data from clinical tr...
Read more15 Dec 2021 07:29
UPDATE 1-Sanofi, GSK announce positive booster data for their COVID-19 vaccine candidate
(Adds details, context)PARIS, Dec 15 (Reuters) - French drugmaker Sanofi and its British partner GlaxoSmithKline said on Wednesday a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immun...
Read more15 Dec 2021 07:05
GSK-Sanofi Covid jab shows 'strong' immune response
(Sharecast News) - A Covid-19 vaccine booster being developed by GlaxoSmithKline and Sanofi has been shown to be effective across all age groups tested, according to data released by the UK drugs firm on Wednesday.
Read more14 Dec 2021 20:21
EXPLAINER-How worried should we be about the Omicron variant?
By Deena BeasleyDec 14 (Reuters) - The Omicron coronavirus variant has been detected in 77 countries since it was first identified three weeks ago, fueling concerns that its large number of mutations will help it spread faster and evade protection...
Read more